Physician profile
Beth K Files
NPI 1679567440
$4,200.36
in general payments reported to CMS, 2019-2025
33 companies · $489 in 2025
The $489 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,140 · 2020: $251 · 2021: $587 · 2022: $557 · 2023: $724 · 2024: $452 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,665.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $641.09 | 2019-2023 | Slynd |
| Astellas Pharma US INC | $597.46 | 2022-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $515.01 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $302.88 | 2019-2025 | |
| Medtronic, INC. | $243.97 | 2022-2025 | Ligasure, Truclear |
| Pfizer INC. | $229.33 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $194.24 | 2021-2025 | |
| Millicent US INC | $193.11 | 2020-2025 | Femring, Intrarosa, Femlyv |
| Lupin INC. | $156.81 | 2019-2021 | |
| Shield Therapeutics INC | $150.07 | 2022-2025 | Accrufer |
| Hologic Sales and Service, LLC | $131.57 | 2019-2024 | Aptima, Thinprep 2000 Processor |
| Biogen, INC. | $117.26 | 2024-2025 | Zurzuvae |
| Evofem Biosciences, INC. | $90.24 | 2021-2024 | |
| Coopersurgical, INC. | $71.95 | 2023-2024 | Wallach Cryosurgical Equipment, Paragard T 380a |
| Merck Sharp & Dohme LLC | $69.31 | 2020-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $56.50 | 2019-2020 | |
| Avanos Medical | $52.13 | 2019-2023 | On-Q* Pump and Accessories |
| Myovant Sciences INC. | $49.04 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $44.47 | 2019 | |
| Organon LLC | $40.75 | 2021-2023 | Nexplanon |
| Ethicon US, LLC | $34.05 | 2025 | Evarrest |
| Aspira Women'S Health INC | $30.67 | 2024 | Ova1 |
| Aroa Biosurgery Incorporated | $24.50 | 2025 | |
| Daiichi Sankyo INC. | $22.37 | 2020 | |
| Acessa Health INC. | $21.70 | 2019 | |
| Smith+Nephew, INC. | $19.34 | 2019 | |
| Vertical Pharmaceuticals, LLC | $16.40 | 2019 | |
| Duchesnay USA Incorporated | $15.11 | 2019 | |
| Exact Sciences Corporation | $15.10 | 2023 | Cologuard Collection Kit |
| Covidien Lp | $14.75 | 2019 | |
| Sumitomo Pharma America, INC. | $14.46 | 2023 | Myfembree |
| Avion Pharmaceuticals | $12.70 | 2021 | |
| Ascend Therapeutics US, LLC | $12.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Files listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.